Maternofetal consequences of Coxiella burnetii infection in pregnancy: a case series of two outbreaks
A high complication rate of Q fever in pregnancy is described on the basis of a limited number of cases. All pregnant women with proven Q fever regardless of clinical symptoms should therefore receive long-term cotrimoxazole therapy. But cotrimoxazole as a folic acid antagonist may cause harm to the...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
9 December 2012
|
| In: |
BMC infectious diseases
Year: 2012, Volume: 12, Pages: 1-7 |
| ISSN: | 1471-2334 |
| DOI: | 10.1186/1471-2334-12-359 |
| Online Access: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/1471-2334-12-359 Verlag, kostenfrei, Volltext: https://doi.org/10.1186/1471-2334-12-359 
|
| Author Notes: | Katharina Boden, Andreas Brueckmann, Christiane Wagner-Wiening, Beate Hermann, Klaus Henning, Thomas Junghanss, Thomas Seidel, Michael Baier, Eberhard Straube and Dirk Theegarten |
| Summary: | A high complication rate of Q fever in pregnancy is described on the basis of a limited number of cases. All pregnant women with proven Q fever regardless of clinical symptoms should therefore receive long-term cotrimoxazole therapy. But cotrimoxazole as a folic acid antagonist may cause harm to the fetus. We therefore investigated the Q fever outbreaks, Soest in 2003 and Jena in 2005, to determine the maternofetal consequences of Coxiella burnetii infection contracted during pregnancy. |
|---|---|
| Item Description: | Gesehen am 12.10.2018 |
| Physical Description: | Online Resource |
| ISSN: | 1471-2334 |
| DOI: | 10.1186/1471-2334-12-359 |